DK0716611T3 - Fremgangsmåde til at reducere myocardielæsion under akut myocardieinfarkt - Google Patents

Fremgangsmåde til at reducere myocardielæsion under akut myocardieinfarkt

Info

Publication number
DK0716611T3
DK0716611T3 DK94929047T DK94929047T DK0716611T3 DK 0716611 T3 DK0716611 T3 DK 0716611T3 DK 94929047 T DK94929047 T DK 94929047T DK 94929047 T DK94929047 T DK 94929047T DK 0716611 T3 DK0716611 T3 DK 0716611T3
Authority
DK
Denmark
Prior art keywords
myocardial infarction
acute myocardial
esterase inhibitor
pct
recombinant
Prior art date
Application number
DK94929047T
Other languages
English (en)
Inventor
Willem Theodoor Hermens
Cornelis Erik Hack
Original Assignee
Sanquin Bloedvoorziening
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanquin Bloedvoorziening filed Critical Sanquin Bloedvoorziening
Application granted granted Critical
Publication of DK0716611T3 publication Critical patent/DK0716611T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electrotherapy Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK94929047T 1993-09-01 1994-08-31 Fremgangsmåde til at reducere myocardielæsion under akut myocardieinfarkt DK0716611T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93202572 1993-09-01
PCT/NL1994/000208 WO1995006479A1 (en) 1993-09-01 1994-08-31 Method to reduce myocardial injury during acute myocardial infarction

Publications (1)

Publication Number Publication Date
DK0716611T3 true DK0716611T3 (da) 2002-05-21

Family

ID=8214075

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94929047T DK0716611T3 (da) 1993-09-01 1994-08-31 Fremgangsmåde til at reducere myocardielæsion under akut myocardieinfarkt

Country Status (10)

Country Link
US (1) US6090777A (da)
EP (1) EP0716611B1 (da)
JP (2) JP4077030B2 (da)
AT (1) ATE212859T1 (da)
AU (1) AU678064B2 (da)
DE (1) DE69429816T2 (da)
DK (1) DK0716611T3 (da)
ES (1) ES2171465T3 (da)
PT (1) PT716611E (da)
WO (1) WO1995006479A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19829014A1 (de) * 1998-06-30 2000-01-05 Centeon Pharma Gmbh Modifizierter C1-Esterase-Inhibitor zur Blockierung der Infektiosität von HIV
US7008645B2 (en) * 1998-07-14 2006-03-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of inhibiting restenosis using bisphosphonates
CA2426115A1 (en) * 2003-04-18 2004-10-18 Victor Gurewich Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots
US10517883B2 (en) * 2003-06-27 2019-12-31 Zuli Holdings Ltd. Method of treating acute myocardial infarction
US20060051407A1 (en) * 2003-06-27 2006-03-09 Yoram Richter Method of treating ischemia-reperfusion injury
US20070196367A1 (en) * 2006-02-22 2007-08-23 Valentin Dinu Methods of preventing and treating Alzheimer's disease, age related macular degeneration and other diseases involving extra-cellular debris through the inhibition of the complement system
US20090010916A1 (en) * 2006-06-22 2009-01-08 Victor Gurewich C-1 Inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis
LT3028716T (lt) 2006-10-10 2020-12-10 Regenesance B.V. Komplemento slopinimas nervų regeneracijos pagerinimui
CN104870475B (zh) 2012-10-25 2019-11-08 美国比奥维拉迪维股份有限公司 抗补体C1s抗体和其用途
DK2914291T3 (da) 2012-11-02 2022-05-16 Bioverativ Usa Inc Anti-komplement-c1s-antistoffer og anvendelser deraf
ES2609070T3 (es) * 2013-02-28 2017-04-18 Csl Behring Gmbh Agente terapéutico para el embolismo de líquido amniótico
CA2901225C (en) * 2013-03-08 2023-09-19 Csl Behring Gmbh Treatment and prevention of remote ischemia-reperfusion injury
US9993427B2 (en) 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture
BR112015023207A8 (pt) 2013-03-15 2018-01-23 Shire Viropharma Inc composições de ci-inh e métodos para prevenção e tratamento de desordens associadas à deficiência de inibidor de c1 esterase.
JP2017501968A (ja) * 2013-06-28 2017-01-19 ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー 第ｘｉｉ因子インヒビターおよびｃ１−インヒビターを使用する組合せ療法
WO2016164358A1 (en) 2015-04-06 2016-10-13 True North Therapeutics, Inc. Humanized anti-c1s antibodies and methods of use thereof
HUE073475T2 (hu) 2016-10-12 2026-01-28 Bioverativ Usa Inc C1s elleni antitestek és alkalmazási eljárásaik

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3228502A1 (de) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung des c1-inaktivators und seine verwendung
FR2601034B1 (fr) * 1986-07-03 1989-11-17 Pasteur Institut Inhibiteur de l'activite de la c1-esterase plasmatique (c1-inhibiteur) et d'autres enzymes proteolytiques du groupe des proteases a serine, son procede de preparation, acides nucleiques codant pour cet inhibiteur, methodes de detection d'affections correlees aux defauts dudit inhibiteur a l'aide d'anticorps ou de sondes nucleotidiques et medicaments contenant ledit inhibiteur de synthese
EP0497833A1 (en) * 1989-10-27 1992-08-12 Stichting Centraal Laboratorium van de Bloedtransfusiedienst van het Nederlandse Rode Kruis C1 inhibitor muteins and uses thereof
WO1992022320A1 (en) * 1991-06-14 1992-12-23 Genentech, Inc. C1 inhibitor variants and treating inflammatory response with c1 inhibitor

Also Published As

Publication number Publication date
AU678064B2 (en) 1997-05-15
DE69429816T2 (de) 2002-09-19
JPH09501946A (ja) 1997-02-25
ATE212859T1 (de) 2002-02-15
AU7823994A (en) 1995-03-22
WO1995006479A1 (en) 1995-03-09
US6090777A (en) 2000-07-18
ES2171465T3 (es) 2002-09-16
DE69429816D1 (de) 2002-03-21
EP0716611B1 (en) 2002-02-06
JP2008056705A (ja) 2008-03-13
EP0716611A1 (en) 1996-06-19
JP4077030B2 (ja) 2008-04-16
PT716611E (pt) 2002-06-28

Similar Documents

Publication Publication Date Title
DK0716611T3 (da) Fremgangsmåde til at reducere myocardielæsion under akut myocardieinfarkt
MY129293A (en) The use of mmp-13 selective inhibitors for the treatment of osteoarthristis and other mmp-mediated disorders
MY129998A (en) Saccharin derivative proteolytic enzyme inhibitors
AU7321598A (en) Use of cholinesterase inhibitors to treat disorders of attention
NO952228D0 (no) Anvendelse av lamotrigin ved behandling av neurologiske lesjoner relatert til traumatiske skader
HU9204029D0 (en) Proteolytic enzym inhibitors
BG97068A (bg) Фармацевтичен състав и метод за постигане на терапевтичен ефект
NZ595193A (en) Modified Proteases That Inhibit Complement Activation
EP0283675A3 (en) Dental plaque and dental caries inhibiting agent and compositions containing such an agent
BR9713400A (pt) Processos e compostos para inibir liberação de peptìdeo beta-amilóide e/ou sua sìntese.
WO1998033491A3 (en) Treatment of arrhythmias via inhibition of a multifunctional calcium/calmodulin-dependent protein kinase
PL322576A1 (en) Transdermally administered therapeutic agent containing inhibitors of angiotensin convertase
DE69410254D1 (de) Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente
UA41355C2 (uk) Засіб для лікування нейро-сніду
DE69333639D1 (en) Trypsininhibitoren
AU7934900A (en) Method of screening for inhibitors of asp2
HU9501146D0 (en) 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity
CO5570661A2 (es) Combinaciones que comprenden inhibidores de cox-2 y aspirina
PL327818A1 (en) Novel medical application of ace inhibitor in treating dipeptic symptoms
CZ157795A3 (en) Pharmaceutical preparations for treating prostatitis
CA2170739A1 (en) Method to reduce myocardial injury during acute myocardial infarction
AU5857899A (en) Use of tgf-beta inhibitors for treating cerebral disorders
DK0722460T3 (da) Peptidderivater der er terapeutisk aktive i blodkoaguleringskaskaden, fremgangsmåde til fremstilling heraf og farmaceutiske
IL136225A0 (en) Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
AU4390597A (en) Combination therapy for treatment of arthritic diseases